Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imaging Therapeutics is a medical technology company that developed advanced imaging software for the assessment of musculoskeletal conditions. The company's core technology, including the B-Score and iView platforms, utilizes proprietary algorithms to analyze bone micro-architecture and cartilage health from standard medical imaging like X-rays and MRIs. These tools were designed to improve the early diagnosis and monitoring of osteoarthritis and osteoporosis by providing quantitative data on joint health. The company's innovations aimed to bridge the gap between traditional imaging and the need for precise, patient-specific diagnostic metrics. In 2012, the company was acquired by Conformis to enhance its patient-specific orthopedic implant technology and preoperative planning capabilities. The integration of this technology allowed for more accurate mapping of patient anatomy for customized joint replacement surgeries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Imaging Therapeutics.